Music |
Video |
Movies |
Chart |
Show |
CDK4/6 Inhibitors Combined with Endocrine Therapy in PALOMA-3 and MONALEESA-3 - Medpage Today (MedPage Today) View | |
CDK4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer (VJOncology) View | |
Emerging evidence on the role of CDK4/6 inhibitors in early BC (BGICSTV) View | |
Key Takeaways from ESMO: CDK4/6 Inhibitors for Metastatic HR+/HER2- Breast Cancer (PracticeUpdate) View | |
FDA Approval of Ribociclib for Metastatic Breast Cancer (OncLive) View | |
Ribociclib for HR+ Advanced Breast Cancer (OncLive) View | |
ASCO 2022: DESTINY-Breast04, PALOMA-2, rEECur (VJOncology) View | |
Kisqali, un iCDK diferente (Esmeeting Eventos y Congresos) View | |
Breast Cancer ASCO 2022 Highlights - OncBrothers (Rohit and Rahul Gosain) with Dr. Sara Tolaney (OncBrothers: Practice-Changing Cancer Discussions) View | |
() View |